{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.02",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "16.02",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE871Z01013",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": 20000,
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Dr Lalchand. Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lalchand-lab-fallingrising-3749643",
        "imagepath": "",
        "date": "2025-12-06 01:37:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Performance and Market Context</strong></p>\n<p>Over the past week, Dr Lalchandani Labs has seen its share price drop by 6.18%, a stark contrast to the Sensex’s marginal gain of 0.01% during the same period. This underperformance extends to the one-month horizon, where the stock has declined by 15.31%, while the Sensex advanced by 2.70%. Such a divergence indicates that the stock is currently facing headwinds that are not affecting the broader market or its sector peers to the same extent.</p>\n<p>Despite these recent setbacks, the stock has delivered a respectable 12.31% gain year-to-date, outperforming the Sensex’s 9.69% rise. Over the last year, the stock’s 8.52% return also surpasses the benchmark’s 4.83%. However, the longer-term picture is less favourable, with a three-y..."
      },
      {
        "title": "How has been the historical performance of Dr Lalchand. Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dr-lalchand-lab-3703832",
        "imagepath": "",
        "date": "2025-11-15 00:15:07",
        "description": "Answer:\nThe historical performance of Dr Lalchand. Lab shows a declining trend in net sales and profitability over the past few years, with a significant drop in total operating income from 11.28 Cr in Mar'22 to 4.45 Cr in Mar'25. The operating profit margin has fluctuated, peaking at 28.9% in Mar'24 before falling to 23.37% in Mar'25. Profit before tax also saw a decline, moving from 1.25 Cr in Mar'22 to 0.40 Cr in Mar'25, while profit after tax decreased from 0.93 Cr in Mar'22 to 0.42 Cr in Mar'25. The company’s total assets decreased from 18.12 Cr in Mar'22 to 15.75 Cr in Mar'25, and total liabilities also saw a reduction from 18.12 Cr to 15.75 Cr in the same period. Cash flow from operating activities has been stagnant, with no inflow reported in the last two years, although there was a net cash inflow of 1.00 Cr in Mar'25.\n\nBreakdown:\nDr Lalchand. Lab's financial performance has shown a notable decline..."
      },
      {
        "title": "When is the next results date for Dr Lalchand. Lab?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dr-lalchand-lab-3691192",
        "imagepath": "",
        "date": "2025-11-11 23:19:45",
        "description": "Dr Lalchand. Lab is scheduled to declare its results on 14 November 2025...."
      },
      {
        "title": "Why is Dr Lalchand. Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lalchand-lab-fallingrising-3687285",
        "imagepath": "",
        "date": "2025-11-10 23:27:21",
        "description": "As of 10-Nov, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 20.23, which reflects a decrease of Rs 1.06 or 4.98%. The stock has underperformed its sector by 3.4% today and opened with a loss of 4.98%. It has shown erratic trading patterns, not trading on 3 out of the last 20 days, and has touched an intraday low of Rs 20.23. Additionally, the delivery volume has decreased by 23.08% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 9.73%, while it has shown a year-to-date increase of 19.70%.\n\nIn the broader market context, the Sensex has only decreased by 0.53% over the past week, suggesting that the stock's decline is more pronounced than the overall market trend. While the stock has performed well year-to-date and over the past year, with increases of 19.70% and 12.39% respectively, its long-term p..."
      },
      {
        "title": "Why is Dr Lalchand. Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lalchand-lab-fallingrising-3605211",
        "imagepath": "",
        "date": "2025-10-08 23:36:40",
        "description": "As of 08-Oct, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 21.58, reflecting a decrease of Rs 1.13 or 4.98%. The stock has underperformed its sector by 5% today and opened with a significant loss of 4.89%. It has also touched an intraday low of Rs 21.58, indicating a challenging trading day. Over the past week, the stock has decreased by 4.98%, and its performance over the last month shows a decline of 16.97%. Despite these short-term challenges, the stock has shown a year-to-date increase of 27.69%, although it has underperformed the benchmark Sensex, which has risen by 4.65% during the same period. The stock's trading activity has been erratic, with no trades on 4 out of the last 20 days, but there has been a rise in investor participation, with delivery volume increasing by 36.36% compared to the 5-day average.\n\nBroader Market Context: In the context of the broade..."
      }
    ],
    "total": 53,
    "sid": "1002986",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Fund Raising",
      "datetime": "16-Dec-2025",
      "details": "Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2025 inter alia to consider and approve fixation of the record date; ? determination of the issue price; ? determination of the rights entitlement ratio; and ? such other terms and conditions as may be required in accordance with applicable laws subject to receipt of necessary statutory and regulatory approvals.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On December 15 2025",
      "datetime": "15-Dec-2025",
      "details": "Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 433.31 Lakhs to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently) subject to receipt of statutory / regulatory approvals in accordance with the amended SEBI (Issuer of Capital and Disclosure Requirements) Amendment Regulations 2025 (the SEBI ICDR Regulations) and other applicable regulations and subject to necessary approvals as may be required.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
      "datetime": "15-Dec-2025",
      "details": "Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholders as on record date (to be determined and specified subsequently)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(22 Dec 2025)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Dr Lalchand. Lab falling/rising?

2025-12-06 01:37:46

Short-Term Price Performance and Market Context

Over the past week, Dr Lalchandani Labs has seen its share price drop by 6.18%, a stark contrast to the Sensex’s marginal gain of 0.01% during the same period. This underperformance extends to the one-month horizon, where the stock has declined by 15.31%, while the Sensex advanced by 2.70%. Such a divergence indicates that the stock is currently facing headwinds that are not affecting the broader market or its sector peers to the same extent.

Despite these recent setbacks, the stock has delivered a respectable 12.31% gain year-to-date, outperforming the Sensex’s 9.69% rise. Over the last year, the stock’s 8.52% return also surpasses the benchmark’s 4.83%. However, the longer-term picture is less favourable, with a three-y...

Read More

How has been the historical performance of Dr Lalchand. Lab?

2025-11-15 00:15:07

Answer: The historical performance of Dr Lalchand. Lab shows a declining trend in net sales and profitability over the past few years, with a significant drop in total operating income from 11.28 Cr in Mar'22 to 4.45 Cr in Mar'25. The operating profit margin has fluctuated, peaking at 28.9% in Mar'24 before falling to 23.37% in Mar'25. Profit before tax also saw a decline, moving from 1.25 Cr in Mar'22 to 0.40 Cr in Mar'25, while profit after tax decreased from 0.93 Cr in Mar'22 to 0.42 Cr in Mar'25. The company’s total assets decreased from 18.12 Cr in Mar'22 to 15.75 Cr in Mar'25, and total liabilities also saw a reduction from 18.12 Cr to 15.75 Cr in the same period. Cash flow from operating activities has been stagnant, with no inflow reported in the last two years, although there was a net cash inflow of 1.00 Cr in Mar'25. Breakdown: Dr Lalchand. Lab's financial performance has shown a notable decline...

Read More

When is the next results date for Dr Lalchand. Lab?

2025-11-11 23:19:45

Dr Lalchand. Lab is scheduled to declare its results on 14 November 2025....

Read More

Why is Dr Lalchand. Lab falling/rising?

2025-11-10 23:27:21

As of 10-Nov, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 20.23, which reflects a decrease of Rs 1.06 or 4.98%. The stock has underperformed its sector by 3.4% today and opened with a loss of 4.98%. It has shown erratic trading patterns, not trading on 3 out of the last 20 days, and has touched an intraday low of Rs 20.23. Additionally, the delivery volume has decreased by 23.08% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 9.73%, while it has shown a year-to-date increase of 19.70%. In the broader market context, the Sensex has only decreased by 0.53% over the past week, suggesting that the stock's decline is more pronounced than the overall market trend. While the stock has performed well year-to-date and over the past year, with increases of 19.70% and 12.39% respectively, its long-term p...

Read More

Why is Dr Lalchand. Lab falling/rising?

2025-10-08 23:36:40

As of 08-Oct, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 21.58, reflecting a decrease of Rs 1.13 or 4.98%. The stock has underperformed its sector by 5% today and opened with a significant loss of 4.89%. It has also touched an intraday low of Rs 21.58, indicating a challenging trading day. Over the past week, the stock has decreased by 4.98%, and its performance over the last month shows a decline of 16.97%. Despite these short-term challenges, the stock has shown a year-to-date increase of 27.69%, although it has underperformed the benchmark Sensex, which has risen by 4.65% during the same period. The stock's trading activity has been erratic, with no trades on 4 out of the last 20 days, but there has been a rise in investor participation, with delivery volume increasing by 36.36% compared to the 5-day average. Broader Market Context: In the context of the broade...

Read More

View All News